GSA Capital Partners’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,165
| Closed | -$348K | – | 1683 |
|
|
2023
Q4 | $348K | Buy |
+4,165
| New | +$348K | 0.03% | 1028 |
|
|
2022
Q4 | – | Sell |
-5,748
| Closed | -$278K | – | 1552 |
|
|
2022
Q3 | $278K | Buy |
+5,748
| New | +$278K | 0.04% | 982 |
|
|
2021
Q4 | – | Sell |
-38,942
| Closed | -$1.39M | – | 1472 |
|
|
2021
Q3 | $1.39M | Buy |
+38,942
| New | +$1.39M | 0.14% | 156 |
|
|
2020
Q1 | – | Sell |
-72,066
| Closed | -$765K | – | 1156 |
|
|
2019
Q4 | $765K | Buy |
+72,066
| New | +$765K | 0.09% | 365 |
|
|
2017
Q4 | – | Sell |
-12,900
| Closed | -$187K | – | 1604 |
|
|
2017
Q3 | $187K | Buy |
+12,900
| New | +$187K | 0.01% | 1466 |
|
|
2017
Q2 | – | Sell |
-131,502
| Closed | -$1.69M | – | 1725 |
|
|
2017
Q1 | $1.69M | Buy |
+131,502
| New | +$1.69M | 0.09% | 332 |
|
|
2016
Q1 | – | Sell |
-117,931
| Closed | -$1.23M | – | 1716 |
|
|
2015
Q4 | $1.23M | Buy |
117,931
+99,287
| +533% | +$1.04M | 0.06% | 546 |
|
|
2015
Q3 | $125K | Buy |
+18,644
| New | +$125K | 0.01% | 1639 |
|
|
2015
Q2 | – | Sell |
-167,074
| Closed | -$1.13M | – | 1979 |
|
|
2015
Q1 | $1.13M | Buy |
+167,074
| New | +$1.13M | 0.05% | 765 |
|